# EDGAR Filing Document

**Accession Number:** 0000784199
**File Stem:** 0001628280-26-043059
**Filing Date:** 2026-6
**Character Count:** 7244
**Document Hash:** 62ef6a0f9409a0ac9cc07f22783b66d7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-043059.hdr.sgml**: 20260615

**ACCESSION NUMBER**: 0001628280-26-043059

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260611

**FILED AS OF DATE**: 20260615

**DATE AS OF CHANGE**: 20260615

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** GREEN ANDREW M
- **CENTRAL INDEX KEY:** 0001191000

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13165
- **FILM NUMBER:** 261089620

**MAIL ADDRESS:**
- **STREET 1:** ARTIVION INC
- **STREET 2:** 1655 ROBERTS BLVD
- **CITY:** KENNESAW
- **STATE:** GA
- **ZIP:** 30144
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ARTIVION, INC.
- **CENTRAL INDEX KEY:** 0000784199
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 592417093
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 1655 ROBERTS BOULEVARD N W
- **CITY:** KENNESAW
- **STATE:** GA
- **ZIP:** 30144
- **BUSINESS PHONE:** 7704193355

**MAIL ADDRESS:**
- **STREET 1:** 1655 ROBERTS BOULEVARD N W
- **CITY:** KENNESAW
- **STATE:** GA
- **ZIP:** 30144

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CRYOLIFE INC
- **DATE OF NAME CHANGE:** 19940526

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>GREEN ANDREW M<br><sub>(Last) (First) (Middle)</sub><br>1655 ROBERTS BLVD., NW<br><sub>(Street)</sub><br>KENNESAW, GA 30144<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-11 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_SVP, Regulatory and Quality_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>ARTIVION, INC. [ AORT ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-06-11 |  | M |  | 14001<sup>(1)</sup> | A | $18.44 | 74260 | D |  |
| Common Stock | 2026-06-11 |  | S |  | 14001<sup>(1)</sup> | D | 20.707<sup>(2)</sup> | 60259 | D |  |
| Common Stock | 2026-06-11 |  | M |  | 30000<sup>(1)</sup> | A | $11.03 | 90259 | D |  |
| Common Stock | 2026-06-11 |  | S |  | 30000<sup>(1)</sup> | D | 20.694<sup>(3)</sup> | 60259 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Options (Right to buy) | $18.44 | 2026-06-11 |  | M |  |  | 14001<sup>(1)</sup> | 2023-02-23<sup>(4)</sup> | 2029-02-23 | Common Stock | 14001 | $0 | 0 | D |  |
| Stock Options (Right to buy) | $11.03 | 2026-06-11 |  | M |  |  | 30000<sup>(1)</sup> | 2023-11-08<sup>(5)</sup> | 2029-11-08 | Common Stock | 30000 | $0 | 0 | D |  |

---

### Footnotes:

(1) The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026.

(2) Reflects weighted average price. Range of prices were between $20.25 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

(3) Reflects weighted average price. Range of prices were between $20.24 to $21.02. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

(4) Stock options vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023.

(5) Stock options vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

**Signature:** /s/ Andrew M. Green  
**Date:** 2026-06-15

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**